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Background: Exercise intolerance limits chronic restrictive respiratory failure (CRF)
patients from participating in daily activities. The specific modalities that could improve
exercise tolerance in these patients remain to be established.
Objective: To investigate exercise endurance and associated physiological responses with
non-invasive ventilation (NIV) during exercise in restrictive CRF patients.
Methods: Eighteen patients (63711 years, total lung capacity (TLC) ¼ 59716% of
predicted value) performed maximal exercise in spontaneous breathing conditions (MWLE)
and during two constant workload exercise (CWLE) tests at 75% Pmax, with or without NIV
in random order. ‘‘NIV Responders’’ were defined by an increase in CWLE duration of more
than 50% when using NIV.
Results: For the whole group, CWLE duration when using NIV increased from 5.674.6 to
9.678.1min. Increase in CWLE duration correlated with reduction in heart rate and
oxygen desaturation, and dyspnea relief during exercise. NIV responders (n ¼ 9) showed
more severe lung restriction (TLC: 2.670.7 versus 3.571.1 L; forced vital capacity:
1.070.16 versus 1.4670.38 L). At the end of MWLE, responders had a lower Vt (0.6070.09
versus 0.8970.34 L), a higher dead-space ratio (0.5170.06 versus 0.3870.12) and lower
oxygen pulse (4.571.2 versus 7.473.9ml/beat).
Conclusion: In severely restrictive patients, NIV during exercise significantly improved
exercise duration and tolerance and increased alveolar ventilation.
Trial registration: The enrollment of the patients started before July 1, 2005.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
re EFCR, CHU de Grenoble, BP217X 38043, Grenoble cedex 09, Grenoble, France. Tel.: +334 76 76 55 16;
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Severe chest wall deformities, such as kyphoscoliosis and
tuberculosis sequellae may lead to secondary chronic
restrictive respiratory failure (CRF). In these patients,
long-term nocturnal non-invasive mechanical ventilation
(NIV) is now recognized as first line therapy. NIV has been
reported to improve daytime arterial blood gases, survival
and to reduce rates of hospitalizations.1–3 Chest wall
diseases represent 30% of home-treated NIV patients in
Europe i.e. approximately 8000 patients.4
As these patients’ exhibit increased survival, it becomes
necessary to focus on their persistent disability and alterations
in quality of life. Exercise intolerance and dyspnea are among
the major complaints preventing patients with severe re-
strictive chest wall disease from participating in activities of
daily life. Pulmonary rehabilitation may be of value for these
patients in whom respiratory symptoms and diminished health-
related quality of life may be observed. To date, there is no
formal evidence-based guidelines for exercise activities in
restrictive lung disease, and ‘expert opinion based on
pathophysiology and clinical experience is recommended’.5
Ambulatory oxygen therapy improves dyspnea but not a 6min
walking distance, thus suggesting a limited interest for such a
treatment during rehabilitation in restrictive patients.6 Using
NIV during daily exercise could be a part of the rehabilitation
program but few data are available on this strategy.
The use of NIV during exercise has been studied in chronic
obstructive pulmonary disease patients (COPD) since the
early 1990s.7–15 For such patients, NIV during exercise may
improve exercise endurance and reduce dyspnea.15 To our
knowledge, only two studies have assessed the role of NIV
during exercise in CRF patients.16,17 One study reported
improvement in endurance time and reduction in breath-
lessness17 in a small population (n ¼ 7 patients) whereas the
other study16 did not find any improvement. Although the
latter study evaluated the response, during exercise, NIV
compared with spontaneous breathing also included a small
number of patients (n ¼ 8). Moreover, the mean preset
inspiratory positive airway pressure (IPAP) (13.7 cmH2O) led
to a moderate increase in minute ventilation during exercise
(18%) which may have modified the benefits of NIV. Since
exercise limitation in chest wall restrictive patients may be
related to the severity of the restrictive disorder, it is
important to study the efficacy of NIV in relation to (i) the
severity of the underlying disease and (ii) the ability of NIV
to maximize the increase in minute ventilation during
exercise. This prospective randomized trial set out to study
the acute effects of the application of support ventilation as
an aid to increase exercise endurance in a group of CRF
patients with a broad range of functional impairment.
Materials and methods
Patients
Patients were eligible for the study if they presented the
following criteria:(i) restrictive thoracic disease (idiopathic kyphoscoliosis,
tuberculosis sequellae, poliomyelitis sequellae withrespiratory involvement) without bronchial obstruction
[forced expiratory volume 1 s (FEV1)/ forced vital
capacity (FVC) 475%];(ii) stable state for more than 3 months;
(iii) previously diagnosed chronic respiratory failure treated
by nocturnal NIV for more than 6 months (PaCO24
45mmHg before the initiation of NIV) without other
causes of restrictive disorders such as progressive
neuro-muscular disease. This study was approved by
the university hospital ethics committee and all
patients signed a written informed consent in order to
participate. This research complies with the Helsinki
Declaration.Study design
Patients were seen on two different occasions 1 week apart.
On the first visit, patients underwent pulmonary function
tests, a maximal incremental exercise test (MWLE) and a
6min walking test (6MWT). On a second visit, patients were
initially adapted to the use of NIV during exercise, and then
were allowed to rest for 30min. Patients subsequently
performed two constant workload exercise tests (CWLE) at
75% of peak workload, with and without NIV in a random
order. Subjects were allowed to rest during 30–45min
between the two tests.
Respiratory function and maximal workload
exercise testing
Spirometry and thoracic gas volumes were measured using
Pitot pneumotachograph and pressure plethysmograph
(MEDICAL GRAPHICS Corporation, St. Paul, MN, USA). sniff
nasal inspiratory pressure (SNIP) was determined at func-
tional residual capacity using a pressure sensor (Validy-
ne7200 cm H2O) connected to a digital recorder (Direc NEP
System 200, Raytech Instruments Inc.; Vancouver; Canada)
according to ATS/ERS statement. A 6MWTwas performed in
ambient air along a straight 30m long corridor. All these
tests were performed according to the ATS guidelines
statement.18–20 Arterial blood gases (Radiometer, Cophen-
hagen) were performed at rest, at least 4 h after the end of
nocturnal NIV treatment.
Maximal workload exercise test was performed on an
electromechanically braked cycle Ergometer (900PC, ERGO-
LINE, Germany). Work rate was increased every minute by
10% of the expected maximal workload until exhaustion.
Minute ventilation (VE), oxygen uptake (VO2), carbon
dioxide exhalation (VCO2), respiratory rate (RR), tidal
volume (Vt) were measured using breath-by-breath auto-
mated exercise metabolic system (Sensormedics, Vmax 229;
Yorba Linda, CA, USA). Peak power (Wpeak) was determined
as the highest work rate that the patient completed during 1
full minute.
Constant workload exercise testing (CWLE)
The two endurance tests were performed at 75% Wpeak on
the same cycle-ergometer, with NIV or in spontaneous
breathing (SB) in random order. Expired gases were
collected in a mixing chamber for analysis of ventilatory
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Figure 1 Experimental setting for the two constant workload exercises (a) with non-invasive ventilation, (b) spontaneous breathing
and (c) photo.
Ventilatory support during exercise 713and metabolic variables. VO2, VCO2, RR, Vt were averaged
over 20 s time intervals. For the test in spontaneous
breathing, the patient was connected via a mouth-piece to
a two-way non-re-breathing valve (Model 2700, Hans
Rudolph Inc., Kansas City, MO USA); the exhalation port
was connected to the mixing chamber (see Figure 1b). For
the test with NIV, the exhalation valve of the ventilator was
connected to the mixing chamber with a 30mm diameter
tubing (see Figure 1a).
The patient warmed up at the lowest available work rate
(20W). The workload was then abruptly increased until the
predetermined workload and continued until exhaustion. At
the end of each minute, the patient indicated his level of
dyspnea. The test was over when the patient could not
maintain exercise because of dyspnea, fatigue or could not
maintain 55 cycles/min.
All the tests were performed at the beginning of the
afternoon.
Both during MWLE and CWLE, 12-lead electrocardiogram
was monitored. SpO2 was also continuously monitored.
There was no oxygen supplementation even in case ofdesaturation. End-exercise arterial blood gases were
sampled by direct arterial sampling.Non-invasive positive pressure ventilation (NIV)
(Figure 1a–c)
The ventilatory mode used for exercise was pressure support
ventilation (PSV) in all patients. To avoid bias related to the
choice of device, a single ventilator was used for all the
patients (SMARTAIR +, AIROX, Pau, France). Settings during
exercise were specifically tailored for appropriate ventila-
tion during exercise and were systematically different from
the nigh time settings. The patient chose the best-tolerated
interface (nasal mask, naso-buccal mask, mouth-piece).
IPAP was increased until the patient had a comfortable
respiratory sensation (‘enough air’ at each insufflation).
Flow trigger was set at the most sensitive value that
prevented involuntary triggering during expiration. Expira-
tory trigger was set at 50% of maximal inspiratory flow. In
order to avoid underestimation of VO2 due to continuous
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Table 1 Patient Characteristics (n ¼ 18).
Cause of respiratory failure 16 KS/2 TS
Age, Years 63711
Men/women 11/7
BMI, kg/m2 2576
TLC, l (% of pred value) 3.071.0 (59716)
FEV1, l (% of pred value) 0.9970.33 (4479)
FVC, l (% of pred value) 1.370.4 (4477)
FEV1/FVC, % 79710
SNIP, mmHg 45.0713.2
PaO2, mmHg 7377
PaCO2, mmHg 4375
PH 7.4270.03
HCO3, mmol/l 27.171.7
Ppeak, W 51722
VO2 peak, l 0.7870.36
6MWT, m 3927131
KS: kyphoscoliosis; TS: tuberculosis sequellae; BMI: body
mass index; TLC: total lung capacity; FEV1: forced expiratory
volume in 1 s; FVC: forced vital capacity; SNIP: sniff nasal
inspiratory pressure; Ppeak: maximal work rate obtained
during incremental exercise test; VO2 peak: maximal O2
consumption during incremental exercise test. 6MWT: Six
minute walk test distance.
J.-C. Borel et al.714flow in the breathing circuit favored by positive end
expiratory pressure (PEEP), we deliberately avoided PEEP
in the ventilator settings.
Responders versus non-responders to acute NIV
during exercise
We considered as ‘responders to NIV’, patients who
increased CWLE time under NIV by more than 50% compared
with spontaneous breathing. The threshold of 50% was
chosen because it corresponds to approximately two times
the coefficient of variance of test–retest CWLE time in COPD
patients at the same exercise load.21
Statistical analysis
Results are expressed as mean7SD. NCSS 97 (Kaysville,
Utah, USA) software was used for the statistical analysis.
Correlations were analyzed using non-parametric correla-
tion Spearman test. Comparison between CWLE, under
either NIV or spontaneous breathing was done with non-
parametric paired test (Wilcoxon test).
Comparison between responders and non-responders to
NIV were made using a non-parametric unpaired test
(Mann–Withney test). For the two endurance tests (with
NIV and in SB), ventilatory, metabolic and cardiac variables
were compared at iso-time as defined by the longest
duration achieved under either condition.
For all tests, a significance level of po0.05 was used.
Results
Patients (Table 1)
Eighteen CRF patients [Total lung capacity (TLC) ¼ 59716%
of predicted value] with a mean age of 63711 years were
included in the study. All had significant reduction in lung
volumes (mean FVC of 4477% of predicted value) and none
had significant bronchial obstruction (FEV1/FVC ratio of
79710%). Nocturnal NIV had been initiated for 776 years on
the basis of chronic hypoventilation (mean PaCO2 at
initiation of NIV: 52712mmHg). All patients used their NIV
at nighttime, but none was dependant upon respiratory
assistance during the daytime. At the time of inclusion,
mean PaCO2 had improved with the regular use of nocturnal
NIV (4375mmHg). However, all patients complained of
dyspnea during activities of daily life. 6MWT distance was
reduced (3927131m i.e. 80724% of predicted value) with a
mean value of dyspnea on a Borg scale of 472 at the end of
the test. The severity of impairment during exercise was
also demonstrated by the mean VO2peak ¼ 1274ml/min/kg
obtained during MWLE.
Effects of NIV during constant workload exercise in
the whole group (n ¼ 18) (Table 2)
The mean NIV pressure support adjusted for exercise was
1972 cm H2O. One patient chose to perform the test with a
mouthpiece, nine with a nasal mask and eight with a naso-
buccal mask. We did not find that the type of interface had asignificant impact on the results (w2 ¼ NS). CWLE time
increased by 71% with NIV (p ¼ 0.01). Iso-time exercises VO2
and VCO2 were not significantly different using NIV or during
SB. With NIV compared to SB, minute ventilation (VE)
increased by 1677 l/min (po0.001) both by increasing tidal
volume (Vt) by 0.670.2 litter (po0.001) and reducing
respiratory rate (RR) by 475/min (po0.01). Mean SpO2
increased by 476% (po0.01) with NIV. Mean heart rate (HR)
was also significantly reduced with NIV at iso-time
(p ¼ 0.04).
Several factors were associated with the increase in
endurance time obtained with NIV. The increase in CWLE
time during NIV significantly correlated with the reduction
in exercise oxygen desaturation (r ¼ 0.67, p ¼ 0.006)
(Figure 2a). Moreover, the increase in CWLE time was
related to the reduction in heart rate with NIV (r ¼ 0.53,
p ¼ 0.03) (Figure 2c). Finally, CWLE time correlated with
the reduction in dyspnea at iso-time (r ¼ 0.60, p ¼ 0.02)
(Figure 2b).
Comparison between responders and non-
responders to NIV(i) Spontaneous breathing endurance test: Despite NIV-
responders exhibiting a shorter duration of CWLE
than non-responders during spontaneous breathing
(p ¼ 0.05), the former had more severe desaturation
(po0.01), lower Vt (p ¼ 0.02) and tended to have
lower VE (p ¼ 0.06) at the end of this test (Table 2).(ii) Ventilatory and cardiovascular changes induced by NIV
in responders and non-responders: Exercise tidal
volume increased by 109741% of spontaneously breath-
ing tidal volume in responders whereas it increased by
ARTICLE IN PRESS
Table 2 Constant-workload exercise (CWLE at 75% Ppeak) during spontaneous breathing and NIV for the whole group
(n ¼ 18) and comparison between NIV responders (n ¼ 9) and non-responders (n ¼ 9).
Total, n ¼ 18 Responders, n ¼ 9 Non-responders, n ¼ 9
SB NIV SB NIV SB NIV
Work rate, watt 39717 3178 43722
Endurance-time, min 5.674.6 9.678.1 4.072.5 12.379.3y 7.175.8y 6.976.1
VE iso-time l/min 2678 41713 2378 37711y 3077 45714z
RR iso-time /min 3578 3177 3677 2975y 35710 3379
Vt iso-time, l 0.7770.3 1.3770.4 0.6370.1 1.2870.3y 0.9270.4y 1.4570.4z
HR iso-time, b/min 127721 123717 125721 118713 129721 128720
SpO2 iso-time, % 8777 9173
 8377 9173y 9174y 9173
VO2 iso-time l/min 0.8770.3 0.8970.3 0.7570.3 0.7570.3 0.9870.3 1.070.4
VCO2 iso-time l/min 0.7570.3 0.7570.3 0.6370.3 0.6570.3 0.8670.3 0.8570.3
Dys iso-time, Borg 572 473 471 271y 672 672
SB: spontaneous breathing; NIV: non invasive ventilation; VE: minute ventilation; RR: respiratory rate; Vt: tidal volume; HR: heart rate;
VO2: O2 consumption; VCO2: CO2 exhalation; Dys: dyspnea (modified Borg scale). For the two endurance tests (with NIV and
spontaneous breathing), ventilatory, metabolic and cardiac variables were compared at iso-time defined by the longest duration
achieved in either condition.
Comparison between CWLE with NIV versus CWLE in spontaneous breathing for the whole group (po0.05).
yComparison between CWLE with NIV versus CWLE in spontaneous breathing for ‘‘Responders’’ (po0.05).
zComparison between CWLE with NIV versus CWLE in spontaneous breathing for ‘‘Non-responders’’ (po0.05).
yComparison between ‘‘responders’’ and ‘‘non-responders’’ during CWLE in spontaneous breathing (po0.05).
Ventilatory support during exercise 715only 64730% in non-responders (p ¼ 0.03) (Table 2).
Respiratory rate significantly decreased with NIV in the
responders group only (p ¼ 0.01) (Table 2). Overall,
responders tended to increase VE to a greater extent
(70724% versus 52720% in responders and non-
responders, respectively (p ¼ 0.17)) (Table 2). Again,
the mean HR during exercise tended to be reduced by
NIV (p ¼ 0.1) whilst SpO2 was significantly increased
(p ¼ 0.008) (Table 2). As a consequence, dyspnea score
at iso-time exercise was relieved with NIV (p ¼ 0.03) in
the responder group only (Table 2).(iii) Lung function and exercise parameters associated with
a positive response with NIV.Differences in lung function as well in exercise response
were associated with a positive response to NIV support
during exercise. Thus, responders had a lower TLC (2.670.7
versus 3.571.1 litter, p ¼ 0.05) and lower FVC (1.070.16
versus 1.4670.38 litter, p ¼ 0.04) than non-responders
(Figure 3). Moreover, responders had higher resting PaCO2
level (respectively 4575mmHg versus 4074, p ¼ 0.04).
At the end of MWLE, both VE (p ¼ 0.04) and peak Vt
(expressed in absolute value p ¼ 0.003), were significantly
lower in responders (Table 3). In addition, functional dead
space ratio (VD/VT ratio) was higher in responders
(p ¼ 0.04). Finally, oxygen pulse at peak exercise was lower
in responders (p ¼ 0.03).
Discussion
In patients with restrictive chronic respiratory failure, acute
NIV during exercise allowed to extend constant workload
exercise time by 71% as a mean value. The degree ofimprovement in CWLE time was significantly related to the
reduction of oxygen desaturation, and the decrease in
dyspnea and heart rate. Responders to NIV during exercise
had lower TLC and FVC. At the end of MWLE in spontaneous
breathing, tidal volume was lower in responders with a
higher dead space on tidal volume ratio and a lower oxygen
pulse. Responders to NIV were thus more severe in terms of
ventilatory failure but also demonstrated more cardiac
limitation as suggested by lower oxygen pulse.NIV efficacy during constant workload exercise:
comparison with previous studies
Only two studies have assessed the impact of acute NIV
during effort in patients with CRF.16,17 Tsuboi et al.17 studied
seven restrictive patients (tuberculosis sequellae) and
demonstrated that NIV significantly prolonged exercise
endurance time. During exercise, NIV effectively decreased
their breathlessness and significantly improved arterial
blood gases measurements. This is in accordance with our
results, even though in Tsuboi’s study, the experimental
setup was different including the use of volumetric
ventilators and performing exercise in the supine position.
In contrast with Tsuboi et al. and the current study, Highcock
et al.16 in a randomized controlled trial including eight
restrictive patients showed a decrease in treadmill walk
distance in patients when using PSV compared to an
unencumbered test. Minute ventilation at breakpoint of
exercise was only slightly increased (+17%) with NIV and
oxygen saturation was not improved in this latter study.
Given that expiratory pressure was set at 4 cm H2O means
that mean pressure support was about 10 cm H2O whereas
this pressure was about 19 cm H2O in the present study thus
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Figure 2 Correlations between constant workload exercise (CWLE) time variation and (a) SpO2 improvement, (b) reduction of the
dyspnea, (c) reduction of heart rate with NIV compared to spontaneous breathing test. (a) Correlation between CWLE time variation
and SpO2 improvement at iso-time with NIV compared to spontaneous ventilation test (n ¼ 18) (b) correlation between CWLE
variation and the reduction of the dyspnea at iso-time with NIV compared to spontaneous ventilation test (n ¼ 16). (c) Correlation
between CWLE time variation and the reduction of heart at iso-time (n ¼ 18). D(Etniv-Etsb): Variation between endurance time with
spontaneous breathing and endurance time with NIV; D(SpO2niv-SpO2sb): Variation between oxygen saturation with spontaneous
breathing and oxygen saturation with NIV at iso-time (iso-time: the highest equivalent timed achieved in the two tests); D(DYSniv-
DYSsb): Variation between dyspnea with spontaneous breathing and dyspnea with NIV at iso-time; D(HRniv-HRSsb): Variation between
heart rate with spontaneous breathing and heart rate with NIV at iso-time.
J.-C. Borel et al.716leading to a 60% increase in minute ventilation. As a
consequence, in our patients, VE was increased by a mean
of 16 l/min and mean oxygen saturation was improved by 4%
on average. In summary, when compared to previous
studies, the strengths of our study are as follows: (i) A
randomized controlled trial design, (ii) a twofold increase in
enrolled patients compared to previous studies, (iii)
ventilator settings permitted a clinically significant increase
in exercise ventilation when using NIV. The current study
also exhibited some limitations. Even if our study is the
largest one in the field, the number of included patients was
relatively small and results need to be replicated in further
large-scale studies. As patients had experienced NIV for a
mean of 776 years, it was impossible to use Sham
ventilation. A placebo effect could be part of the explana-
tion for increase in exercise duration but could not account
for reduction of oxygen desaturation and other physiological
changes associated with NIV.Ventilatory and cardiovascular changes associated
with increased endurance with NIV
The mean range for improvement in exercise duration using
PSV was 71% in this study. This is more than 40–50% of the
improvement previously demonstrated in COPD pa-
tients.7,14,15 In restrictive patients, Naji et al.22 showed an
increase in exercise endurance (treadmill) of a mean of
8.7min, which was associated with a significant improve-
ment in quality of life. One may speculate that the 71%
improvement that we achieved with NIV is at least as
significant. The wide range of change in exercise duration
when using NIV in the present study (i.e. from 2.6 to
+27.5min) as in others14,17,23 illustrates that some patients
benefit greatly from ventilatory support, although others do
not or are even slightly impaired. NIV responders had both
lower TLC and lower FVC which suggests that the most
severe patients are those most likely to benefit. Secondly,
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Figure 3 Forced vital capacity (FVC) and total lung capacity (TLC) for responders and non-responders to NIV during exercise (n ¼ 17
for TLC, n ¼ 18 for FVC).
Table 3 Comparative analysis of maximal exercise workload test between responders and non-responders to NIV during
exercise, n ¼ 18.
Responders (9) Non-responders (9) p
Ppeak, W 45714 57727 ns
HRpeak, b/min 133718 134721 ns
VO2 peak l/min 0.6470.24 0.9170.41 ns
VCO2 peak l/min 0.6370.25 0.8970.39 ns
VE peak, l/min 25.076.3 34.279.61 0.04
Vt peak, l 0.6070.09
 0.8970.34 0.003
Vt peak, (% FVC) 5878 61711 ns
RR peak, /min 4177 40712 ns
O2 Pulse peak, ml/beat 4.571.2
 7.473.9 0.03
(pred value) (5878) (70721)
Vd/Vt (blood gaz n ¼ 12) (6/6) 0.5170.06 0.3870.12 0.04
D(A-a), mmHg 4.7471.18 3.8271.7 ns
PaO2 peak, mmHg (6/6) 59711 72718 0.1
PaCO2 peak, mmHg (6/6) 5175 4475 0.05
pH peak 7.3370.03 7.3570.05 ns
SaO2 peak, (%) 8577 9174 0.08
Ppeak: Maximal work rate obtained during incremental exercise test; VO2peak: Maximal O2 consumption during incremental exercise
test; HRpeak: heart rate; VEpeak: minute ventilation; Vtpeak: tidal volume (expressed in absolute value and as percentage of forced vital
capacity); RRpeak: respiratory rate; O2 Pulsepeak: oxygen pulse (VO2/HR ratio—expressed in ml/beat and percentage of predicted
value) Vd/Vt ratios were determined with blood gases analyze. D(A-a): Alvelo-arterial difference.
po0.05.
Ventilatory support during exercise 717during the MWLE in spontaneous breathing, responders had
lower minute ventilation with lower tidal volume. As a
consequence, reduced alveolar ventilation, higher VD/VT
ratio and greater oxygen desaturation were observed at the
end of exercise. Thus, one can understand that in
responders the two-fold increase in Vt and 70% increase in
VE provided by NIV have improved gas exchange and
subsequent exercise ability. Surprisingly, VE was also
significantly improved with NIV in non-responders (+52%)
without benefit in terms of exercise tolerance. Ventilatory
mechanical limitation was presumably not the main me-chanism limiting exercise in these patients, and peripheral
muscle fatigue may have a potential role. Even without NIV,
these patients were able to perform CWLE for a longer
duration (7.175.8min versus 4.072.5, p ¼ 0.05) with
limited oxygen desaturation. In such less severe patients,
NIV does not seem to provide any additional effect.
Another important difference between responders and
non-responders could have been the ability to adjust cardiac
output during exercise. Responders had lower oxygen pulse
at the end of the MWLE suggesting limited ability to increase
cardiac ejection during heavy exercise. Previous studies
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J.-C. Borel et al.718have demonstrated that cardiac output might be involved in
exercise limitation in patients with thoracic or pulmonary
restriction (see below).24,25
Mechanisms explaining improvement in exercise
ability using NIV
A large increase in VE (61723%) and also Vt were obtained
for the whole group when using NIV during exercise. The
significant correlations between improvement in CWLE
duration and SpO2 improvement and dyspnea relief using
NIV during exercise suggest that improving alveolar ventila-
tion and gas exchange and/or minimizing symptoms by using
NIV are the main factors explaining the increase in exercise
duration. The present study is the first to demonstrate that
an increase in minute ventilation sufficient to improve
alveolar ventilation during exercise and presumably to avoid
oxygen desaturation improves exercise tolerance in patients
with thoracic restriction. Tuggey and Elliot26 have demon-
strated that a high-pressure support (+19 cm H2O in our
study) is needed to achieve blood gases normalization
whereas more limited support allows rapid unloading of
respiratory muscles.
The reduction in oxygen pulse at the end of exercise
observed in the most severe patients in the present study
suggests that reduced ejection fraction may contribute to
exercise limitation. In a model of thoracic restriction in
healthy volunteers, Miller et al.25 showed a fall in cardiac
output during moderate intensity exercise. Also, in primary
pulmonary hypertension, patients had low oxygen pulse
value during exercise corresponding to a limited increase in
stroke volume.27,28 In our study, NIV could reduce heart rate
directly by preventing oxygen desaturation and indirectly by
limiting hypoxic vasoconstriction and reducing pulmonary
hypertension. This could lead to a higher stroke volume and
allow reduction in heart rate at the same cardiac output for
a given level of exercise.29 Moreover, a higher Vt during NIV
being associated with a lung volume-dependant decrease in
sympathetic tone may have had additional effects in
decreasing sympathetic activation.30,31
Considering that oxygen desaturation is one of the main
factors limiting exercise in restrictive patients, one can
argue that oxygen supplementation during exercise could
have led to similar results than NIV application. However,
whereas oxygen therapy could relieve dyspnea, its use did
not improve the 6min walking distance in patients with
kyphoscoliosis.6 In patients with tuberculosis sequellae,
Tsuboı¨ et al.17 compared oxygen therapy versus VNI+O2
and showed a significant increase in endurance time (from
227764 to 4657201 s). These data suggest that VNI per se
has a specific and synergistic role with oxygen in improving
exercise capacity in CRF.
Clinical implications and conclusion
In severely restrictive patients, NIV during exercise in-
creases exercise duration, improves exercise tolerance and
alveolar ventilation. Both the presence of low vital capacity
at rest (one liter or less) and inefficient ventilation during
exercise (high VD/VT ratio) could discriminate responders
and non-responders to NIV during exercise.The magnitude of changes in exercise endurance is much
more pronounced than previously reported in COPD. Thus,
with NIV, restrictive patients could be able to exercise
longer and therefore get a greater training effect during a
pulmonary rehabilitation program. This however remains to
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